Dubai, January 15 / WAM / The Emirates Pharmaceutical Corporation revealed the presence of an additional product, “S26 AR”, within the scope of the voluntary and precautionary recall of Nestlé infant formula products, which are used under medical supervision only.
In order to preserve health and safety, the Corporation announced the operations affected by the withdrawal decision, which are 5185080661, 5271080661, and 5125080661.
This measure comes as a result of one of the production inputs containing traces of Bacillus cereus bacteria, which may produce Cereulide, which may lead to health disorders, including food poisoning and some digestive symptoms such as nausea, vomiting, and abdominal pain.
The Corporation confirmed that, in coordination with Nestlé, all relevant batches available in distributors’ warehouses have been seized, while continuing to complete procedures for withdrawing any remaining quantities from the market, in accordance with the approved regulatory frameworks and in cooperation with the relevant regulatory authorities in the country, to ensure the removal of the affected batches from all sales outlets, including electronic stores.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
